Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 24th: Fulgent Genetics, Inc. (FLGT ...

BioCryst Pharmaceuticals (NASDAQ:BCRX) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on ...

The investment manager Neil Woodford has revealed plans to launch a new fund less than two years from the implosion of his ...

Over the last twelve months, investors have made a dramatic show of their confidence in the synthetic biology industry. Despite current financial ...

Unity Biotechnology (NASDAQ:UBX) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to ...

Talent a ‘game changer’ in attracting investment, says UAE official Arab News Read More: Talent a ‘game changer’ in attracting investment, says ...

The #1 Healthcare investment opportunities for 2021 – Glenn Freeman Livewire Markets Read More: The #1 Healthcare investment opportunities for 2021

BEND, Ore., Jan. 6, 2021 /PRNewswire/ — Serán Bioscience today announced that healthcare investment firm Vivo Capital has made a majority investment ...

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

It has been an eventful year for the volatile biotech sector, which has been in the spotlight from the onset of 2020, ...